أفضل أطباء الكلى - توب -344 أطباء
Experience
2018
Private Istanbul Medipol Hospital
2018
Medipol University Camlica Hospital
2018
Medipol Camlica Hospital
2013 - 2018
Medipol Mega University Hospital
2011 - 2013
Yuzuncu Yil University Hospital
2010 - 2011
Gulhane Military Medical Academy
2010 - 2013
Yuzuncu Yil University Hospital
2010 - 2011
Gulhane Military Medical Academy
2010 - 2011
Gulhane Military Medical Academy
2010 - 2013
Yuzuncu Yil University Faculty of Medicine
2009
University of Toronto SickKids Hospital
2004 - 2008
Private Van-Etfal Pediatric Diseases
1999 - 2004
Yuzuncu Yil University Hospital
Education
2010
Yuzuncu Yil University, Pediatric Nephrology
2004
Yuzuncu Yil University, Pediatrics
1998
Ege University, Faculty of Medicine
اقرأ المزيد
| تكلفة استشارة الطبيب | السعر عند الطلب |
| غسيل الكلى | $200 |
| استئصال الكلية | $8000 - $12000 |
EXPERIENCE*
2019 - Present, Istanbul/Istanbul/Turkey
MEMORIAL ATAŞEHİR HOSPITAL
General Surgeon
2012 - 2019, Diyarbakır/Diyarbakır/Turkey
DİCLE UNIVERSITY FACULTY OF MEDICINE
General Surgeon
2011 - 2012, Van/Van/Turkey
VAN REGIONAL TRAINING AND RESEARCH HOSPITAL
General Surgeon
2009 - 2011, Van/Van/Turkey
HAKKARİ STATE HOSPITAL
General Surgeon
2004 - 2009, Van/Van/Turkey
YÜZÜNCÜYIL UNIVERSITY FACULTY OF MEDICINE
General Surgeon
2002 - 2004, Van/Van/Turkey
HACIBEKİR HEALTH CENTER
General Practitioner
*EDUCATION*
2018 - 2019, Diyarbakır/Turkey
Associate Professor
2015, Ohio/USA
OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER
Neck Dissection Training
2012 - 2018, Diyarbakır/Turkey
Assistant Professor
1996 - 2002, Adana/Turkey
ÇUKUROVA UNIVERSITY
FACULTY OF MEDICINE - Medical Doctor Education
اقرأ المزيدالاعتمادات:
Biography
Dr. Mehdi Afrit is a Medical Oncologist who practices at Burjeel Specialty Hospital in Sharjah. He has over 11 years of experience caring for and managing cancer patients. He has extensive experience providing chemotherapy, hormonal therapy, immunotherapy, and targeted therapy to patients. He earned a Certificate of Medical Oncology from the Gustave Roussy Institute in Paris, France, where he received training in antitumor chemotherapy and cancer medical treatment. Additionally, he holds an international certificate in breast diseases. He also has a certificate in Good Clinical Practice from Trans Celerate Biopharma Inc. and a certificate in Clinical Trial Management: Good Clinical Practice from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He previously worked for over five years as an Assistant Professor of Medical Oncology at Tunis’s Faculty of Medicine. He later practiced as a Consultant, Medical Oncologist for six years at Arianna’s hospital in Tunisia. He later worked for two years as a Specialist Medical Oncologist at Zulekha Hospital. He was also an investigator in three international clinical trials and holds clinical trial auditing and CRO certifications and a GCP Training Certificate from 2016. He is a member in good standing of the Emirates Oncology Society (EOS), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). His clinical expertise includes but is not limited to the following:
- Oncology care and treatment for chemotherapy, hormonal therapy, immune therapy, and target therapy
- Breast cancer
- Solid tumor diagnosis
- Digestive cancer
- Gynecological cancer
- Lung cancer
- Genitourinary cancer
- Sarcoma
Awards & Achievements
- Award from Himaya Foundations and University of Sharjah
Research & Publications
- Clinicopathological Features of Gastric Cancer in a Cohort of Gulf Council Countries' Patients: A Cross-Sectional Study of 96 Cases. Journal of Oncology Research Reviews & Reports Volume 2(2): 1-3.
- The Burden of Gynecologic Cancers in the UAE. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6.
- The Emirates Oncology Task Force Clinical Practice Guideline on Screening for SARS-CoV-2 in Asymptomatic Adult Cancer Patients Before Anti-Cancer Therapy. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6.
- The State of Cancer Care in the United Arab Emirates in 2020: Challenges and Recommendations, A report by the United Arab Emirates Oncology Task Force. Humaid Al-Shamsi, Humaa Darr, Ibrahim Abu-Gheida , Jawaher Ansari, Martine, Mehdi Afrit, Mohamad H Masri, Mohamed Abuhaleeqa. Gulf J Oncology 2020 Jan;1(32):71-87.
- Primary Bone Lymphoma: Tunisian Multicentric Retrospective Study About 32 Cases. Ben Ayed C, Laabidi S, Said N, Afrit M, Ben Ahmed S, Boussen H. Tunis Med. 2018 May;96(5):269-272.
- First Site of Recurrence After Breast Cancer Adjuvant Treatment in the Era of Multimodality Therapy: Which Imaging for Which Patient During Follow-up? Nesrine M, Mehdi B, Houda EB, Soumaya L, Mehdi A, Bechir Z, Hamouda B. Breast Dis. 2017 Nov 21
الدكتور فيفيك شارما هو جراح ذو خبرة في جراحة استبدال العظام والمفاصل مع أكثر من 14 عامًا من الخبرة. وهو جراح مؤهل لـ D.Ortho و DNB وقد أجرى أكثر من 5000 عملية جراحية معقدة ومراجعة. لديه خبرة في إجراء تقويم مفاصل الورك / الركبة الأساسي والمراجعة ، وقطع عظم الركبة ، بالإضافة إلى علاج هشاشة العظام والتهاب المفاصل والألم. وهو أيضًا عضو مؤسس في مركز التميز في راجستان.
اقرأ المزيد